British Journal of Cancer - Table of Contents alert Volume 118 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 118, Issue 6 (March 2018) In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Corrigenda Also new AOP   Editorial Systemic immune-inflammation index in germ-cell tumours: search for a biological prognostic biomarker Costantine Albany British Journal of Cancer 2018 118 :761 - 762; February 27, 2018; 10.1038/bjc.2018.7   Abstract | Full Text Clinical Studies Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials Shiraj Sen, Kenneth Hess, David S Hong, Aung Naing, Sarina Piha-Paul et al. British Journal of Cancer 2018 118 :763 - 769; February 20, 2018; 10.1038/bjc.2017.480   Abstract | Full Text A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 Victoria K Woodcock, Sally Clive, Richard H Wilson, Vicky M Coyle, Michael R L Stratford et al. British Journal of Cancer 2018 118 :770 - 776; February 13, 2018; 10.1038/bjc.2017.484   Abstract | Full Text Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma Brigitte Dréno, Paolo A Ascierto, Victoria Atkinson, Gabriella Liszkay, Michele Maio et al. British Journal of Cancer 2018 118 :777 - 784; February 13, 2018; 10.1038/bjc.2017.488   Abstract | Full Text Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients Markus Hecht, Friedegund Meier, Lisa Zimmer, Bülent Polat, Carmen Loquai et al. British Journal of Cancer 2018 118 :785 - 792; February 13, 2018; 10.1038/bjc.2017.489   Abstract | Full Text A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma Natalie Cook, Bristi Basu, Donna-Michelle Smith, Aarthi Gopinathan, Jeffry Evans et al. British Journal of Cancer 2018 118 :793 - 801; February 13, 2018; 10.1038/bjc.2017.495   Abstract | Full Text Translational Therapeutics Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer Sifeng Qu, Xinpei Ci, Hui Xue, Xin Dong, Jun Hao et al. British Journal of Cancer 2018 118 :802 - 812; January 30, 2018; 10.1038/bjc.2017.474   Abstract | Full Text Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer Ján Remšík, Radek Fedr, Jirí Navrátil, Lucia Binó, Eva Slabáková et al. British Journal of Cancer 2018 118 :813 - 819; February 20, 2018; 10.1038/bjc.2017.497   Abstract | Full Text PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC Marzia Del Re, Riccardo Marconcini, Giulia Pasquini, Eleonora Rofi, Caterina Vivaldi et al. British Journal of Cancer 2018 118 :820 - 824; March 06, 2018; 10.1038/bjc.2018.9   Abstract | Full Text Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy Christian Daniel Fankhauser, Sophia Sander, Lisa Roth, Oliver Gross, Daniel Eberli et al. British Journal of Cancer 2018 118 :825 - 830; February 27, 2018; 10.1038/bjc.2017.467   Abstract | Full Text Molecular Diagnostics Systemic immune-inflammation index in germ-cell tumours Michal Chovanec, Zuzana Cierna, Viera Miskovska, Katarina Machalekova, Katarina Kalavska et al. British Journal of Cancer 2018 118 :831 - 838; February 27, 2018; 10.1038/bjc.2017.460   Abstract | Full Text IKKa is required in the intestinal epithelial cells for tumour stemness Carlota Colomer, Pol Margalef, Jessica Gonzalez, Anna Vert, Anna Bigas et al. British Journal of Cancer 2018 118 :839 - 846; February 13, 2018; 10.1038/bjc.2017.459   Abstract | Full Text Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer Karen Legler, Ricarda Rosprim, Tosca Karius, Kathrin Eylmann, Maila Rossberg et al. British Journal of Cancer 2018 118 :847 - 856; January 30, 2018; 10.1038/bjc.2017.472   Abstract | Full Text Development and validation of a plasma-based melanoma biomarker suitable for clinical use Ryan Van Laar, Mitchel Lincoln & Barton Van Laar British Journal of Cancer 2018 118 :857 - 866; January 23, 2018; 10.1038/bjc.2017.477   Abstract | Full Text CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells Yuichiro Miki, Masakazu Yashiro, Tomohisa Okuno, Kishu Kitayama, Go Masuda et al. British Journal of Cancer 2018 118 :867 - 877; February 13, 2018; 10.1038/bjc.2017.487   Abstract | Full Text The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients Enrica Rampazzo, Paola Del Bianco, Roberta Bertorelle, Caterina Boso, Alessandro Perin et al. British Journal of Cancer 2018 118 :878 - 886; February 15, 2018; 10.1038/bjc.2017.492   Abstract | Full Text Epidemiology High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors Simone de Vries, Michael Schaapveld, Frederika A van Nimwegen, Katarzyna Józwiak, Pieternella J Lugtenburg et al. British Journal of Cancer 2018 118 :887 - 895; January 30, 2018; 10.1038/bjc.2017.476   Abstract | Full Text Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology Inger Gustavsson, Riina Aarnio, Malin Berggrund, Julia Hedlund-Lindberg, Ann-Sofi Strand et al. British Journal of Cancer 2018 118 :896 - 904; February 13, 2018; 10.1038/bjc.2017.485   Abstract | Full Text Family history of cancer and the risk of childhood solid tumours: a Norwegian nationwide register-based cohort study Ruby Del Risco Kollerud, Karl Gerhard Blaasaas, Bjørgulf Claussen, Per Nafstad, Lisa A Cannon-Albright et al. British Journal of Cancer 2018 118 :905 - 912; February 20, 2018; 10.1038/bjc.2017.493   Abstract | Full Text Risk of cancer in patients with epistaxis and haemoptysis Anne G Ording, Katalin Veres, Dóra K Farkas, Kasper Adelborg & Henrik T Sørensen British Journal of Cancer 2018 118 :913 - 919; February 20, 2018; 10.1038/bjc.2017.494   Abstract | Full Text Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank Jessica S Morris, Kathryn E Bradbury, Amanda J Cross, Marc J Gunter & Neil Murphy British Journal of Cancer 2018 118 :920 - 929; March 08, 2018; 10.1038/bjc.2017.496   Abstract | Full Text Corrigenda Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses' Health Study Claudia Trudel-Fitzgerald, Eric S Zhou, Elizabeth M Poole, Xuehong Zhang, Karin B Michels et al. British Journal of Cancer 2018 118 : e6; January 09, 2018; 10.1038/bjc.2017.437   Abstract | Full Text Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer Takashi Sakaguchi, Hirofumi Yoshino, Masaya Yonemori, Kazutaka Miyamoto, Satoshi Sugita et al. British Journal of Cancer 2018 118 : e7; February 13, 2018; 10.1038/bjc.2017.439   Abstract | Full Text The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia Jon D Emery, Victoria Gray, Fiona M Walter, Shelley Cheetham, Emma J Croager et al. British Journal of Cancer 2018 118 : e8; February 15, 2018; 10.1038/bjc.2017.457   Abstract | Full Text Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array Edward J Saunders, Tokhir Dadaev, Daniel A Leongamornlert, Ali Amin Al Olama, Sara Benlloch et al. British Journal of Cancer 2018 118 : e9; February 13, 2018; 10.1038/bjc.2017.468   Abstract | Full Text Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma A F Hottinger, A Ben Aissa, V Espeli, D Squiban, N Dunkel et al. British Journal of Cancer 2018 118 : e10; January 09, 2018; 10.1038/bjc.2017.469   Abstract | Full Text Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy Peder R Braadland, Guro Giskeødegård, Elise Sandsmark, Helena Bertilsson, Leslie R Euceda et al. British Journal of Cancer 2018 118 : e11; February 20, 2018; 10.1038/bjc.2017.470   Abstract | Full Text miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2 Cong Wang, Wenxue Zhang, Lin Zhang, Xuan Chen, Fang Liu et al. British Journal of Cancer 2018 118 : e12; February 20, 2018; 10.1038/bjc.2017.471   Abstract | Full Text An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma A Linton, Y Y Cheng, K Griggs, L Schedlich, M B Kirschner et al. British Journal of Cancer 2018 118 : e13; February 13, 2018; 10.1038/bjc.2018.3   Abstract | Full Text Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort Anne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, Caroline Paquet, Jean-Yves Pierga et al. British Journal of Cancer 2018 118 : e14; February 20, 2018; 10.1038/bjc.2018.4   Abstract | Full Text A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline Xiaohui Liu, Weimin Zheng, Wansheng Wang, Huali Shen, Linxiao Liu et al. British Journal of Cancer 2018 118 : e15; February 13, 2018; 10.1038/bjc.2018.5   Abstract | Full Text Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium Artitaya Lophatananon, Sarah Stewart-Brown, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch Garcia et al. British Journal of Cancer 2018 118 : e16; February 13, 2018; 10.1038/bjc.2018.6   Abstract | Full Text Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition Christos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick et al. British Journal of Cancer 2018 118 : e17; March 06, 2018; 10.1038/bjc.2018.11   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.